Compensatory Role of Inositol 5-Phosphatase INPP5B to OCRL in Primary Cilia Formation in Oculocerebrorenal Syndrome of Lowe

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2013 Jun 28

PMID 23805271

Citations 28

Authors

Na Luo

Akhilesh Kumar

Michael Conwell

Robert N Weinreb

Ryan Anderson

Yang Sun

Affiliations

Soon will be listed here.

Abstract

Inositol phosphatases are important regulators of cell signaling, polarity, and vesicular trafficking. Mutations in OCRL, an inositol polyphosphate 5-phosphatase, result in Oculocerebrorenal syndrome of Lowe, an X-linked recessive disorder that presents with congenital cataracts, glaucoma, renal dysfunction and mental retardation. INPP5B is a paralog of OCRL and shares similar structural domains. The roles of OCRL and INPP5B in the development of cataracts and glaucoma are not understood. Using ocular tissues, this study finds low levels of INPP5B present in human trabecular meshwork but high levels in murine trabecular meshwork. In contrast, OCRL is localized in the trabecular meshwork and Schlemm's canal endothelial cells in both human and murine eyes. In cultured human retinal pigmented epithelial cells, INPP5B was observed in the primary cilia. A functional role for INPP5B is revealed by defects in cilia formation in cells with silenced expression of INPP5B. This is further supported by the defective cilia formation in zebrafish Kupffer's vesicles and in cilia-dependent melanosome transport assays in inpp5b morphants. Taken together, this study indicates that OCRL and INPP5B are differentially expressed in the human and murine eyes, and play compensatory roles in cilia development.

Citing Articles

Phosphatidylinositol (4,5)-bisphosphate Impacts Ectosome Shedding from Ciliated Sensory Neurons.

Elsayyid M, Semmel A, Prova N, Parekh K, Tanis J bioRxiv. 2025; .

PMID: 39975196 PMC: 11839067. DOI: 10.1101/2025.02.05.636762.

Atypical phenotypes and novel OCRL variations in southern Chinese patients with Lowe syndrome.

Du R, Zhou C, Chen S, Li T, Lin Y, Xu A Pediatr Nephrol. 2024; 39(8):2377-2391.

PMID: 38589698 DOI: 10.1007/s00467-024-06356-y.

Role of lipids in the control of autophagy and primary cilium signaling in neurons.

Hernandez-Caceres M, Pinto-Nunez D, Rivera P, Burgos P, Diaz-Castro F, Criollo A Neural Regen Res. 2023; 19(2):264-271.

PMID: 37488876 PMC: 10503597. DOI: 10.4103/1673-5374.377414.

The Role of Primary Cilia-Associated Phosphoinositide Signaling in Development.

Chen C, Hu J, Ling K J Dev Biol. 2022; 10(4).

PMID: 36547473 PMC: 9785882. DOI: 10.3390/jdb10040051.

Composition, organization and mechanisms of the transition zone, a gate for the cilium.

Park K, Leroux M EMBO Rep. 2022; 23(12):e55420.

PMID: 36408840 PMC: 9724682. DOI: 10.15252/embr.202255420.

References

Gaary E, Rawnsley E, Morse C, Crow H . In utero detection of fetal cataracts. J Ultrasound Med. 1993; 12(4):234-6. DOI: 10.7863/jum.1993.12.4.234. View

Richardson M, Segu Z, Price M, Lai X, Witzmann F, Mechref Y . Alterations in the aqueous humor proteome in patients with Fuchs endothelial corneal dystrophy. Mol Vis. 2010; 16:2376-83. PMC: 2994738. View

Mitchell C, Connolly T, MAJERUS P . Identification and isolation of a 75-kDa inositol polyphosphate-5-phosphatase from human platelets. J Biol Chem. 1989; 264(15):8873-7. View

Rbaibi Y, Cui S, Mo D, Carattino M, Rohatgi R, Satlin L . OCRL1 modulates cilia length in renal epithelial cells. Traffic. 2012; 13(9):1295-305. PMC: 3652247. DOI: 10.1111/j.1600-0854.2012.01387.x. View

Schmid A, Wise H, Mitchell C, Nussbaum R, Woscholski R . Type II phosphoinositide 5-phosphatases have unique sensitivities towards fatty acid composition and head group phosphorylation. FEBS Lett. 2004; 576(1-2):9-13. DOI: 10.1016/j.febslet.2004.08.052. View

Colwill K, Wells C, Elder K, Goudreault M, Hersi K, Kulkarni S . Modification of the Creator recombination system for proteomics applications--improved expression by addition of splice sites. BMC Biotechnol. 2006; 6:13. PMC: 1421398. DOI: 10.1186/1472-6750-6-13. View

Coon B, Mukherjee D, Hanna C, Riese 2nd D, Lowe M, Aguilar R . Lowe syndrome patient fibroblasts display Ocrl1-specific cell migration defects that cannot be rescued by the homologous Inpp5b phosphatase. Hum Mol Genet. 2009; 18(23):4478-91. PMC: 7289333. DOI: 10.1093/hmg/ddp407. View

Hichri H, Rendu J, Monnier N, Coutton C, Dorseuil O, Vargas Poussou R . From Lowe syndrome to Dent disease: correlations between mutations of the OCRL1 gene and clinical and biochemical phenotypes. Hum Mutat. 2010; 32(4):379-88. DOI: 10.1002/humu.21391. View

Bielas S, Silhavy J, Brancati F, Kisseleva M, Al-Gazali L, Sztriha L . Mutations in INPP5E, encoding inositol polyphosphate-5-phosphatase E, link phosphatidyl inositol signaling to the ciliopathies. Nat Genet. 2009; 41(9):1032-6. PMC: 2746682. DOI: 10.1038/ng.423. View

10.

Janne P, Suchy S, Bernard D, MacDonald M, Crawley J, Grinberg A . Functional overlap between murine Inpp5b and Ocrl1 may explain why deficiency of the murine ortholog for OCRL1 does not cause Lowe syndrome in mice. J Clin Invest. 1998; 101(10):2042-53. PMC: 508792. DOI: 10.1172/JCI2414. View

11.

Sarmah B, Winfrey V, Olson G, Appel B, Wente S . A role for the inositol kinase Ipk1 in ciliary beating and length maintenance. Proc Natl Acad Sci U S A. 2007; 104(50):19843-8. PMC: 2148385. DOI: 10.1073/pnas.0706934104. View

12.

Hou X, Hagemann N, Schoebel S, Blankenfeldt W, Goody R, Erdmann K . A structural basis for Lowe syndrome caused by mutations in the Rab-binding domain of OCRL1. EMBO J. 2011; 30(8):1659-70. PMC: 3102282. DOI: 10.1038/emboj.2011.60. View

13.

Bothwell S, Farber L, Hoagland A, Nussbaum R . Species-specific difference in expression and splice-site choice in Inpp5b, an inositol polyphosphate 5-phosphatase paralogous to the enzyme deficient in Lowe Syndrome. Mamm Genome. 2010; 21(9-10):458-66. PMC: 2974198. DOI: 10.1007/s00335-010-9281-7. View

14.

Bothwell S, Chan E, Bernardini I, Kuo Y, Gahl W, Nussbaum R . Mouse model for Lowe syndrome/Dent Disease 2 renal tubulopathy. J Am Soc Nephrol. 2010; 22(3):443-8. PMC: 3060438. DOI: 10.1681/ASN.2010050565. View

15.

Kim J, Lee J, Heynen-Genel S, Suyama E, Ono K, Lee K . Functional genomic screen for modulators of ciliogenesis and cilium length. Nature. 2010; 464(7291):1048-51. PMC: 2929961. DOI: 10.1038/nature08895. View

16.

Praetorius H, Spring K . A physiological view of the primary cilium. Annu Rev Physiol. 2005; 67:515-29. DOI: 10.1146/annurev.physiol.67.040403.101353. View

17.

Lowe M . Structure and function of the Lowe syndrome protein OCRL1. Traffic. 2005; 6(9):711-9. DOI: 10.1111/j.1600-0854.2005.00311.x. View

18.

Schneider I, Houston D, Rebagliati M, Slusarski D . Calcium fluxes in dorsal forerunner cells antagonize beta-catenin and alter left-right patterning. Development. 2007; 135(1):75-84. DOI: 10.1242/dev.004713. View

19.

Novarino G, Akizu N, Gleeson J . Modeling human disease in humans: the ciliopathies. Cell. 2011; 147(1):70-9. PMC: 3202432. DOI: 10.1016/j.cell.2011.09.014. View

20.

Walton D, Katsavounidou G, Lowe C . Glaucoma with the oculocerebrorenal syndrome of Lowe. J Glaucoma. 2005; 14(3):181-5. DOI: 10.1097/01.ijg.0000158850.07732.05. View